Prophylactic Hypogastric Artery Ligation during Placenta Percreta Surgery: A Retrospective Cohort Study

Abstract

Objective To evaluate if prophylactic hypogastric artery ligation (HAL) decreases surgical blood loss and blood products transfused.

Study Design This is a retrospective cohort study comparing patients with placenta percreta undergoing prophylactic HAL at the time of cesarean hysterectomy versus those who did not. Data were presented as means ± standard deviations, proportions, or medians with interquartile ranges. Demographic and clinical data were compared in the groups using Student's t-test for normally distributed data or the Mann–Whitney U test for nonnormally distributed data. Fisher's exact test was used for proportions and categorical variables. Data are reported as significant where p was <0.05.

Results There were 26 patients included in the control group with no HAL and 11 patients included in the study group. Estimated blood loss for the study group was 1,000 mL versus 800 mL in the control. Units of PRCBs transfused were 4.5 units in the study group versus 2 units for the control group. None of these measures were found to be statistically significant.

Conclusion Our data suggest there was no benefit in the use of prophylactic HAL in decreasing surgical blood loss or amount of blood products transfused in patients who had a cesarean hysterectomy performed for placenta percreta.

Précis Prophylactic HAL does not decrease blood loss during surgery for placenta percreta.

Keywords

abnormally invasive placentation - placenta percreta - cesarean hysterectomy - hemorrhage - hypogastric artery ligation

Disclosure

This is original research from Hackensack University Medical Center, Maternal Fetal Medicine Department. Dr. Kuhn, Dr. Martimucci, Dr. Al-Khan, Dr. Bilinksi, Dr. Zamudio and Dr. Alvarez Perez were active participants and we wish to submit this research to the American Journal of Perinatology Reports. This research is not under consideration for publication in another journal. The authors report no biomedical financial interest or potential conflicts of interest.

• References

• 1 Paraskevaides E, Noelke L, Afrasiabi M. Internal iliac artery ligation (IIAL) in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol 1993; 52 (01) 73-75
• 2 Kidney DD, Nguyen AM, Ahdoot D, Bickmore D, Deutsch LS, Majors C. Prophylactic perioperative hypogastric artery balloon occlusion in abnormal placentation. AJR Am J Roentgenol 2001; 176 (06) 1521-1524
• 3 Burchell RC. Physiology of internal iliac artery ligation. J Obstet Gynaecol Br Commonw 1968; 75 (06) 642-651
• 4 Papp Z, Tóth-Pál E, Papp C. , et al. Hypogastric artery ligation for intractable pelvic hemorrhage. Int J Gynaecol Obstet 2006; 92 (01) 27-31
• 5 Fargeaudou Y, Morel O, Soyer P. , et al. Persistent postpartum hemorrhage after failed arterial ligation: value of pelvic embolisation. Eur Radiol 2010; 207 (07) 1777-1785
• 6 Arango HA, Hoffman MS, Roberts WS. , et al. Does ligation of the hypogastric artery at the time of radical hysterectomy and lymphadenectomy decrease blood loss? Results of a prospective randomized trial. Int J Gynecol Cancer 1999; 9 (02) 137-140
• 7 Al-Khan A, Gupta V, Illsley NP. , et al. Maternal and fetal outcomes in placenta accreta after institution of team-managed care. Reprod Sci 2014; 21 (06) 761-771
• 8 Upson K, Silver RM, Greene R, Lutomski J, Holt VL. Placenta accreta and maternal morbidity in the Republic of Ireland, 2005-2010. J Matern Fetal Neonatal Med 2014; 27 (01) 24-29
• 9 Meehan FP, Casey C, Costello JN, Connolly CE. Placenta previa percreta with bladder involvement. Obstet Gynecol Surv 1989; 44 (12) 835-840
• 10 Hansch E, Chitkara U, McAlpine J, El-Sayed Y, Dake MD, Razavi MK. Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol 1999; 180 (6, Pt 1): 1454-1460
• 11 Clark SL, Phelan JP, Yeh SY, Bruce SR, Paul RH. Hypogastric artery ligation for obstetric hemorrhage. Obstet Gynecol 1985; 66 (03) 353-356
• 12 Salim R, Chulski A, Romano S, Garmi G, Rudin M, Shalev E. Precesarean prophylactic balloon catheters for suspected placenta accreta: a randomized controlled trial. Obstet Gynecol 2015; 126 (05) 1022-1028
• 13 Mei Y, Luo D, Lin Y. Clinical application of prophylactic internal iliac artery balloon occlusion combined with uterine artery embolization in patients with abnormally invasive placenta. J Matern Fetal Neonatal Med 2017; 30: 1-6
• 14 Cali G, Forlani F, Giambanco L. , et al. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol 2014; 179: 36-41